Carey Oconnor Kolaja's Net Worth

$232 Thousand

Estimate Recalculated Sep 8, 2024 07:35PM EST

Who is Carey Oconnor Kolaja?

Carey Oconnor Kolaja does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Revance Therapeutics, Inc..

SEC CIK

Carey Oconnor Kolaja's CIK is 0001848717

Past Insider Trading and Trends

2021 was Carey Oconnor Kolaja's most active year for acquiring shares with 4 total transactions. Carey Oconnor Kolaja's most active month to acquire stocks was the month of April. 2023 was Carey Oconnor Kolaja's most active year for disposing of shares, totalling 2 transactions. Carey Oconnor Kolaja's most active month to dispose stocks was the month of May. 2023 saw Carey Oconnor Kolaja paying a total of $45,300.00 for 11,949 shares, this is the most they've acquired in one year. In 2023 Carey Oconnor Kolaja cashed out on 5,000 shares for a total of $70,600.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Revance Therapeutics, Inc. (RVNC) Snapshot price: $6.56

Investor

Carey Oconnor Kolaja owns 31,561 units of Common Stock which is worth $207,040.16. From 2021 to 2024 Carey Oconnor Kolaja acquired a total of 34,061 shares in Revance Therapeutics, Inc. at a cost of $45,300.00, Carey also disposed a total of 2,500 shares of Revance Therapeutics, Inc. equalling to $70,600.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+90.57%
15K
—
—
31.56K
May 1
Form 4
—
0
$23.18
-$25,300.00
16.56K
Jun 15
Form 4
+27.13%
3.53K
—
—
16.56K
May 3
Form 4/A
—
0
—
—
0
May 4
Form 4
+86.95%
6.06K
—
—
13.03K
May 4
Form 4
+10.71%
674
—
—
6.97K
May 5
Form 4
∞
6.29K
—
—
6.29K
Mar 1
Form 3
—
0
—
—
0
No matching records found